Should We Reevaluate Liver Transplantation as an Alternative to Resection for the Treatment of Intrahepatic Cholangiocarcinoma?
- 16 April 2020
- journal article
- editorial
- Published by Ovid Technologies (Wolters Kluwer Health) in Liver Transplantation
- Vol. 26 (6), 748-750
- https://doi.org/10.1002/lt.25780
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The ILTS Consensus Conference on Transplant Oncology: Setting the StageTransplantation, 2020
- Analysis of Liver Resection Versus Liver Transplantation on Outcome of Small Intrahepatic Cholangiocarcinoma and Combined Hepatocellular‐Cholangiocarcinoma in the Setting of CirrhosisLiver Transplantation, 2020
- Propensity‐Matched Analysis of Patients with Mixed Hepatocellular‐Cholangiocarcinoma and Hepatocellular Carcinoma Undergoing Liver Transplantation†Liver Transplantation, 2018
- Liver Transplant for CholangiocarcinomaGastroenterology Clinics of North America, 2018
- Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-seriesThe Lancet Gastroenterology & Hepatology, 2018
- Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intentBritish Journal of Surgery, 2017
- Systemic and Adjuvant Therapies for Intrahepatic CholangiocarcinomaCancer Control, 2017
- Liver transplantation for “very early” intrahepatic cholangiocarcinoma: International retrospective study supporting a prospective assessmentHepatology, 2016
- Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma in Patients Undergoing Liver TransplantationAnnals of Surgery, 2014